Education and Health Notices




31 JANUARY 2013 NEW ZEALAND GAZETTE, No. 11

Trinity Schools’ Trust Board (Attendance Dues) Notice 2013

Under section 36(2) of the Private Schools Conditional Integration Act 1975, and acting with authority delegated by the Minister of Education, I approve that the attendance dues payable to Trinity Schools’ Trust Board in respect of any pupil at Hadlow Preparatory School (Masterton) shall be a maximum of $\$1,000.00 (exclusive of GST) per pupil per annum, and in respect of any pupil at St Matthew’s Collegiate (Masterton) and Rathkeale College

(Masterton) shall be a maximum of $\$1,270.00 (exclusive of GST) per pupil per annum in 2013, a maximum of $\$1,570.00 (exclusive of GST) per pupil per annum in 2014, and a maximum of $\$1,850.00 (exclusive of GST) per pupil per annum from 2015.

Dated at Wellington this 23rd day of January 2013.

MARILYN SCOTT, Acting Group Manager, Education, Curriculum and Performance, Ministry of Education.

go455

Health

Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Tykerb
Active Ingredient: Lapatinib ditosilate monohydrate 405mg equivalent to lapatinib free base 250mg
Dosage Form: Tablet
New Zealand Sponsor: GlaxoSmithKline (NZ) Limited
Manufacturer: Glaxo Operations UK Limited (t/a Glaxo Wellcome Operations), Hertfordshire, United Kingdom

Dated this 24th day of January 2013.

DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).

go481

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Aristocal
Active Ingredient: Calcium carbonate 1250mg equivalent to elemental calcium 500mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Beximco Pharmaceuticals New Zealand Limited
Manufacturer: Beximco Pharmaceuticals Limited, Gazipur, Bangladesh

Product: Artelac Rebalance
Active Ingredient: Sodium hyaluronate 1.5mg/mL
Dosage Form: Eye drops, solution
New Zealand Sponsor: Bausch & Lomb (NZ) Limited
Manufacturer: Tubilux Pharma SpA, Rome, Italy

Product: Parafast
Active Ingredient: Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Marksans Pharma Limited, Goa, India

Product: Zoledronic Alphapharm
Active Ingredient: Zoledronic acid monohydrate 0.8528mg/mL equivalent to zoledronic acid 0.8mg/mL
Dosage Form: Concentrate for infusion
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Hikma Farmaceutica (Portugal) Lda, Sintra, Portugal



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2013, No 11





✨ LLM interpretation of page content

🎓 Trinity Schools’ Trust Board (Attendance Dues) Notice 2013

🎓 Education, Culture & Science
23 January 2013
Private Schools, Attendance Dues, Hadlow Preparatory School, St Matthew’s Collegiate, Rathkeale College, Masterton
  • MARILYN SCOTT, Acting Group Manager, Education, Curriculum and Performance, Ministry of Education

🏥 Consent to the Distribution of a New Medicine (Tykerb)

🏥 Health & Social Welfare
24 January 2013
Medicines, Distribution Consent, Tykerb, Lapatinib ditosilate monohydrate, GlaxoSmithKline
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health

🏥 Consent to the Distribution of New Medicines (Aristocal, Artelac Rebalance, Parafast, Zoledronic Alphapharm)

🏥 Health & Social Welfare
24 January 2013
Medicines, Distribution Consent, Aristocal, Artelac Rebalance, Parafast, Zoledronic Alphapharm
  • DR DON MACKIE, Chief Medical Officer, Clinical Leadership, Protection and Regulation Business Unit, Ministry of Health